Capital Advisors Inc Novartis Ag Transaction History
Capital Advisors Inc
- $5.41 Billion
- Q2 2025
A detailed history of Capital Advisors Inc transactions in Novartis Ag stock. As of the latest transaction made, Capital Advisors Inc holds 1,944 shares of NVS stock, worth $231,938. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,944
Previous 2,066
5.91%
Holding current value
$231,938
Previous $230,000
2.17%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding NVS
# of Institutions
1,552Shares Held
142MCall Options Held
1.64MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA10.6MShares$1.27 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.24 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.08 Billion0.26% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$850 Million0.35% of portfolio
-
Morgan Stanley New York, NY7.06MShares$842 Million0.06% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $257B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...